COVID-19 is responsible for a worldwide pandemic, with a high rate of morbidity and mortality. The increasing evidence of an associated relevant pro-thrombotic coagulopathy has resulted in an increasing use of antithrombotic doses higher than usual in COVID-19 patients. Information on the benefit/risk ratio of this approach is still lacking.

The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience

Pesavento, Raffaele;Ceccato, Davide;Frigo, Anna chiara;Gorgi, Davide;Postal, Anna;Cipriani, Alberto;Criveller, Pietro;Gemelli, Marco;Capone, Federico;Fioretto, Paola;Pagano, Claudio;Rossato, Marco;Avogaro, Angelo;Simioni, Paolo;Prandoni, Paolo;Vettor, Roberto
2020

Abstract

COVID-19 is responsible for a worldwide pandemic, with a high rate of morbidity and mortality. The increasing evidence of an associated relevant pro-thrombotic coagulopathy has resulted in an increasing use of antithrombotic doses higher than usual in COVID-19 patients. Information on the benefit/risk ratio of this approach is still lacking.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3347224
Citazioni
  • ???jsp.display-item.citation.pmc??? 53
  • Scopus 58
  • ???jsp.display-item.citation.isi??? ND
social impact